Global X Genomics & Biotechnology ETF (GNOM:NASDAQ) closed at $66.46 on October 26, 2026, up 1.35% on the day. The stock trades 10.4% below its 52-week high of $74.19 and 61.5% above its 52-week low of $41.16. Global X Genomics & Biotechnology ETF is part of the Miscellaneous sector.
In 252 trading sessions since October 24, 2025, GNOM closed higher on 124 days (49%). Its best day was August 19, 2026 (+13.62%) and its worst was October 6, 2026 (-6.50%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 1 time.
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Find more stocks like GNOM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.